Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.

Johnston AN, Bu W, Hein S, Garcia S, Camacho L, Xue L, Qin L, Nagi C, Hilsenbeck SG, Kapali J, Podsypanina K, Nangia J, Li Y.

Breast Cancer Res. 2018 May 19;20(1):42. doi: 10.1186/s13058-018-0969-z.

2.

Shaping Chromatin in the Nucleus: The Bricks and the Architects.

Sitbon D, Podsypanina K, Yadav T, Almouzni G.

Cold Spring Harb Symp Quant Biol. 2017;82:1-14. doi: 10.1101/sqb.2017.82.033753. Epub 2017 Dec 5.

PMID:
29208640
3.

Essential role for centromeric factors following p53 loss and oncogenic transformation.

Filipescu D, Naughtin M, Podsypanina K, Lejour V, Wilson L, Gurard-Levin ZA, Orsi GA, Simeonova I, Toufektchan E, Attardi LD, Toledo F, Almouzni G.

Genes Dev. 2017 Mar 1;31(5):463-480. doi: 10.1101/gad.290924.116. Epub 2017 Mar 29.

4.

Social networking in tumor cell communities is associated with increased aggressiveness.

Lodillinsky C, Podsypanina K, Chavrier P.

Intravital. 2016 Jan 21;5(1):e1112476. doi: 10.1080/21659087.2015.1112476. eCollection 2016.

5.

Methods to Study Metastasis in Genetically Modified Mice.

Kabeer F, Beverly LJ, Darrasse-Jèze G, Podsypanina K.

Cold Spring Harb Protoc. 2016 Feb 1;2016(2):pdb.top069948. doi: 10.1101/pdb.top069948.

PMID:
26832689
6.

Enrichment of Mammary Basal and Luminal Cells for Cell-of-Origin Metastasis Studies.

Kabeer F, Podsypanina K, Darrasse-Jèze G.

Cold Spring Harb Protoc. 2016 Feb 1;2016(2):pdb.prot078345. doi: 10.1101/pdb.prot078345.

PMID:
26832681
7.

Murine Stem Cell-Based Retrovirus Production for Marking Primary Mouse Mammary Cells for Metastasis Studies.

Beverly LJ, Podsypanina K.

Cold Spring Harb Protoc. 2016 Feb 1;2016(2):pdb.prot078337. doi: 10.1101/pdb.prot078337.

PMID:
26832680
8.

Tissue Dissociation for Metastasis Studies.

Kabeer F, Podsypanina K.

Cold Spring Harb Protoc. 2016 Feb 1;2016(2):pdb.prot078329. doi: 10.1101/pdb.prot078329.

PMID:
26832679
9.

Methods to study primary tumor cells and residual tumor cells in mouse models of oncogene dependence.

Botta C, Darini C, Darrasse-Jèze G, Podsypanina K.

Methods Mol Biol. 2015;1267:381-94. doi: 10.1007/978-1-4939-2297-0_19.

PMID:
25636480
10.

How numbers, nature, and immune status of foxp3(+) regulatory T-cells shape the early immunological events in tumor development.

Darrasse-Jèze G, Podsypanina K.

Front Immunol. 2013 Sep 26;4:292. doi: 10.3389/fimmu.2013.00292. Review.

11.

Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.

Leslie K, Gao SP, Berishaj M, Podsypanina K, Ho H, Ivashkiv L, Bromberg J.

Breast Cancer Res. 2010;12(5):R80. doi: 10.1186/bcr2725. Epub 2010 Oct 7.

12.

Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation.

Reddy JP, Peddibhotla S, Bu W, Zhao J, Haricharan S, Du YC, Podsypanina K, Rosen JM, Donehower LA, Li Y.

Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3728-33. doi: 10.1073/pnas.0910665107. Epub 2010 Feb 3.

13.

Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.

Darrasse-Jèze G, Bergot AS, Durgeau A, Billiard F, Salomon BL, Cohen JL, Bellier B, Podsypanina K, Klatzmann D.

J Clin Invest. 2009 Sep;119(9):2648-62. doi: 10.1172/JCI36628. Epub 2009 Aug 3.

14.
15.

Seeding and propagation of untransformed mouse mammary cells in the lung.

Podsypanina K, Du YC, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H.

Science. 2008 Sep 26;321(5897):1841-4. doi: 10.1126/science.1161621. Epub 2008 Aug 28.

16.

Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant Kras.

Podsypanina K, Politi K, Beverly LJ, Varmus HE.

Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5242-7. doi: 10.1073/pnas.0801197105. Epub 2008 Mar 20.

17.
18.

Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.

Huang S, Podsypanina K, Chen Y, Cai W, Tsimelzon A, Hilsenbeck S, Li Y.

Technol Cancer Res Treat. 2006 Dec;5(6):565-71.

PMID:
17121432
19.

Analysis of PTEN mutation in non-familial pheochromocytoma.

Puc J, Placha G, Wocial B, Podsypanina K, Parsons R, Gaciong Z.

Ann N Y Acad Sci. 2006 Aug;1073:317-31.

PMID:
17102102
20.

Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.

Du Z, Podsypanina K, Huang S, McGrath A, Toneff MJ, Bogoslovskaia E, Zhang X, Moraes RC, Fluck M, Allred DC, Lewis MT, Varmus HE, Li Y.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17396-401. Epub 2006 Nov 7.

21.

Oncogenes come of age.

Varmus H, Pao W, Politi K, Podsypanina K, Du YC.

Cold Spring Harb Symp Quant Biol. 2005;70:1-9. Review.

22.

Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.

Huang S, Li Y, Chen Y, Podsypanina K, Chamorro M, Olshen AB, Desai KV, Tann A, Petersen D, Green JE, Varmus HE.

Genome Biol. 2005;6(10):R84. Epub 2005 Sep 30.

23.

Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.

Zhang X, Podsypanina K, Huang S, Mohsin SK, Chamness GC, Hatsell S, Cowin P, Schiff R, Li Y.

Oncogene. 2005 Jun 16;24(26):4220-31.

PMID:
15824740
24.
25.

Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.

Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, Varmus HE.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15853-8. Epub 2003 Dec 10.

26.

DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.

Wang H, Douglas W, Lia M, Edelmann W, Kucherlapati R, Podsypanina K, Parsons R, Ellenson LH.

Am J Pathol. 2002 Apr;160(4):1481-6.

27.

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.

Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11563-8. Epub 2001 Sep 11.

28.

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.

Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J, Neshat M, Wang H, Yang L, Gibbons J, Frost P, Dreisbach V, Blenis J, Gaciong Z, Fisher P, Sawyers C, Hedrick-Ellenson L, Parsons R.

Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10320-5. Epub 2001 Aug 14.

29.

Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice.

Li Y, Podsypanina K, Liu X, Crane A, Tan LK, Parsons R, Varmus HE.

BMC Mol Biol. 2001;2:2. Epub 2001 Jan 23.

30.

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.

Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R.

Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1563-8.

31.

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R.

Science. 1997 Mar 28;275(5308):1943-7.

32.

The 3'-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites.

Mayford M, Baranes D, Podsypanina K, Kandel ER.

Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13250-5.

Supplemental Content

Loading ...
Support Center